- The looming ‘patent cliff’ facing Big Pharma Financial Times
- Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData Express Pharma
- Pharma industry needs to pivot beyond generics | Policy Circle policycircle.org
- Indian pharma eyes US gains as $63.7 bn patent cliff nears: Analysts Business Standard
The looming ‘patent cliff’ facing Big Pharma – Financial Times
